Filing metadata

Accession number
0001492422-25-000014
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Dec 18, 2025
Reporting period
Dec 16, 2025
Description
Insider transaction

Explore SEC Filings Hub